Skip to main content
TipRanks
Go Ultimate75% OFF

Tandem Diabetes Care (0M0F) Stock Statistics & Valuation Metrics

6 Followers

Total Valuation

Tandem Diabetes Care has a market cap or net worth of $1.40B. The enterprise value is $1.43B.

Market Cap
$1.40B
Enterprise Value
$1.43B

Share Statistics

Tandem Diabetes Care has 69,793,846 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
69,793,846
Owned by Insiders
1.00%
Owned by Institutions
76.83%

Financial Efficiency

Tandem Diabetes Care’s return on equity (ROE) is -1.32 and return on invested capital (ROIC) is -11.88%.

Return on Equity (ROE)
-1.32
Return on Assets (ROA)
-0.23
Return on Invested Capital (ROIC)
-11.88%
Return on Capital Employed (ROCE)
-0.12
Revenue Per Employee
405.89K
Profits Per Employee
-81.88K
Employee Count
2,500
Asset Turnover
1.15
Inventory Turnover
3.76

Valuation Ratios

The current PE Ratio of Tandem Diabetes Care is -27.93. Tandem Diabetes Care’s PEG ratio is -0.18.

PE Ratio
-27.93
PS Ratio
1.30
PB Ratio
10.35
Price to FCF
-38.59
Price to Operating Cash Flow
-95.70
PEG Ratio
-0.18

Income Statement

In the last 12 months, Tandem Diabetes Care had revenue of 1.01B and earned -204.71M in profits. Earnings per share was -3.04.

Revenue
1.01B
Gross Profit
530.85M
Operating Income
-78.12M
Pretax Income
-200.27M
Net Income
-204.71M
EBITDA
-174.70M
Earnings Per Share (EPS)
-3.04

Cash Flow

In the last 12 months, operating cash flow was -14.61M and capital expenditures -21.69M, giving a free cash flow of -36.30M billion.

Operating Cash Flow
-14.61M
Free Cash Flow
-36.30M
Free Cash Flow per Share
-0.52

Dividends & Yields

Tandem Diabetes Care pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.59%
Earnings Yield
-3.52%

Stock Price Statistics

Beta
1.28
52-Week Price Change
14.56%
50-Day Moving Average
17.39
200-Day Moving Average
18.79
Relative Strength Index (RSI)
60.78
Average Volume (3m)
727

Important Dates

Tandem Diabetes Care upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 24, 2027
Ex-Dividend Date
―

Financial Position

Tandem Diabetes Care as a current ratio of 2.55, with Debt / Equity ratio of 286.44%

Current Ratio
2.55
Quick Ratio
2.02
Debt to Market Cap
0.21
Net Debt to EBITDA
-2.03
Interest Coverage Ratio
-9.88

Taxes

In the past 12 months, Tandem Diabetes Care has paid 4.44M in taxes.

Income Tax
4.44M
Effective Tax Rate
-0.02

Enterprise Valuation

Tandem Diabetes Care EV to EBITDA ratio is -120.69, with an EV/FCF ratio of -56.88.

EV to Sales
1.92
EV to EBITDA
-120.69
EV to Free Cash Flow
-56.88
EV to Operating Cash Flow
-141.33

Balance Sheet

Tandem Diabetes Care has $443.08M in cash and marketable securities with $736.54M in debt, giving a net cash position of -$293.46M billion.

Cash & Marketable Securities
$443.08M
Total Debt
$736.54M
Net Cash
-$293.46M
Net Cash Per Share
-$4.20
Tangible Book Value Per Share
$1.94

Margins

Gross margin is 56.65%, with operating margin of -2.35%, and net profit margin of -4.58%.

Gross Margin
56.65%
Operating Margin
-2.35%
Pretax Margin
-4.05%
Net Profit Margin
-4.58%
EBITDA Margin
-1.59%
EBIT Margin
-3.26%

Analyst Forecast

The average price target for Tandem Diabetes Care is $28.60, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
$28.60
Price Target Upside
42.82% Upside
Analyst Consensus
Moderate Buy
Analyst Count
13
Revenue Growth Forecast
6.73%
EPS Growth Forecast
76.54%

Scores

Smart Score
6
AI Score
―